(AP) — Medtronic Inc. said Monday it agreed to pay Abbott Laboratories $400 million to settle patent lawsuits related to the design of vascular stents. As part of the settlement, the two companies agreed not to sue each other over matters related to stents or stent delivery systems for the ...
